Anaphylactic actions of platelet-activating factor

Area of Science:

• Immunology
• Pharmacology

Background:

• Platelet-activating factor (PAF) is a potent mediator of anaphylactoid reactions.
• PAF shares some bioactions with C3a and C5a anaphylatoxins, including smooth muscle contraction and increased vascular permeability.

Purpose of the Study:

• To investigate the distinct bioactions of platelet-activating factor (PAF) compared to C3a and C5a anaphylatoxins.
• To elucidate the mechanisms underlying PAF-induced smooth muscle contraction and desensitization.

Main Methods:

• In vitro and in vivo studies using guinea pig ileum and lung models.
• Assessment of smooth muscle contraction, vascular permeability, and desensitization responses.

Main Results:

• PAF induced a slow, sustained smooth muscle contraction in guinea pig ileum, unlike the rapid, transient contractions caused by C3a and C5a.
• PAF-induced contractions were not inhibited by antihistamines, whereas C3a and C5a effects were.
• PAF desensitized the ileum to itself but not to C3a/C5a, and vice versa, indicating distinct receptor pathways.

Conclusions:

• Platelet-activating factor (PAF) exhibits unique anaphylactic actions separate from C3a and C5a.
• PAF mediates slow muscle contraction independently of histamine release and C3a/C5a receptors.
• PAF represents a distinct pathway in anaphylaxis.